Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.m

Sarcoid-like granulomatosis (endo-/extrathoracic)

Publications

Chopra A, Nautiyal A, Kalkanis A, Judson MA

Drug-Induced Sarcoidosis-Like Reactions.

Chest 2018 Sep;154;664-677 — 2018 Sep — 664-677

Wittram C, Mark EJ, McLoud TC

CT-histologic correlation of the ATS/ERS 2002 classification of idiopathic interstitial pneumonias.

Radiographics : a review publication of the Radiological Society of North America, Inc 2003 Sep-Oct;23;1057-71 — 2003 Sep-Oct — 1057-71

Haramati LB, Lee G, Singh A, Molina PL, White CS

Newly diagnosed pulmonary sarcoidosis in HIV-infected patients.

Radiology 2001 Jan;218;242-6 — 2001 Jan — 242-6

Naccache JM, Antoine M, Wislez M, Fleury-Feith J, Oksenhendler E, Mayaud C, Cadranel J

Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy.

American journal of respiratory and critical care medicine 1999 Jun;159;2009-13 — 1999 Jun — 2009-13